LAST DAY TO SUBMIT YOUR ABSTRACTS: 7th Translational Research Conference: Myelodysplastic Syndromes

 

7^th TRANSLATIONAL RESEARCH CONFERENCE:
MYELODYSPLASTIC SYNDROMES

 

April 23-25, 2020
Mandelieu-La Napoule, France
Chairs: Pierre Fenaux, Uwe Platzbecker, Mikkael Sekeres

 

---

DO NOT MISS THE OPPORTUNITY!
EXTENDED DEADLINE FOR ABSTRACTS
FEBRUARY 26, 2020

---

ABOUT THE CONFERENCE:
The 7^th ESH Conference on Myelodysplastic Syndromes (MDS) is designed to provide time and multiple opportunities for critical discussion and informal scientific interaction with internationally recognized experts in the field. Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates. In separate sessions results from both basic and clinical research will be presented.

  Posters and Brief Oral Communications:
Registered participants are invited to submit their Biology and Clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.

  The meeting will be of interest to:
- Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
- Junior scientists and clinicians (MD, PhD)
- PhD candidates and clinical residents still in-training

  Learning Objectives:
- Learn how to optimally diagnose MDS, by morphological analysis and cytogenetics but also through the use of new tools, mainly for molecular analysis.
- Improve ability to analyze prognostic factors, including new factors (revised IPSS, molecular analysis).
- Review current treatment of MDS in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation.
- Acquire improved knowledge of emerging treatments based on targeted therapies and well conducted clinical trials.

More information

---

 

with the support of*

Diamond Conference Partner

*******

         

Ruby Conference Partners

*******

*ESH conference programmes are developed in strict scientific independence with no input from corporate sponsors.